Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 650x65px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5496 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 53 54 55

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Numico–Danone: investment, 200707–200711 acquisition public cash offer for all shares €12.3b €55/share 2007-07-09
Ansyco–Extrel: quadrupol mass spectrometer, 200707– distribution in Germany by Ansyco 2007-07-01
Max Planck–Advion: mass spectrometry technology, 200706 supply existent Matthias Mann works with Advion technology 2007-06-19
Madaus–Rottapharm: investment, 200706 acquisition 100% of Madaus Pharma from Droege International Group AG by Rottapharm 2007-06-13
Hepa Wash–SEVERAL: investment, 200705 seed financing round €1.1m from private investors 2007-05-29
Thermo Fisher–HighChem: Mass Frontier s/w, 200705 license existent for use with LCQ Fleet Ion Trap Mass Spectrometer 2007-05-29
Noxxon–LCF Rothschild: investment, 200704 investment in Noxxon by Edmond de Rothschild Investment Partners 2007-04-01
EndoArt–Allergan: investment, 200702 acquisition $97m in cash net of excess cash 2007-02-22
Boehringer–Xencor: XmAb technology, 200702–license €na to optimise therapeutic antibodies 2007-02-13
CovalX–Switzerland (govt): grant, 2007– KTI grant for co-developm of cross-linking molecules with Prof Renato Zenobi ETHZ + ABI 2007-01-01
Evocatal–SEVERAL: investment, 2007 seed financing round 2007-01-01
Jacobs Univ–Bremen (govt): grant, 2007–2011 support funding of €23m by City of Bremen 2007-01-01
nAmbition–JPK Instruments: investment, 2007 acquisition of remaining shares by JPK 2007-01-01
Noxxon–TVM: investment, 2007 initial investment of TVM 2007-01-01
Probiodrug–TVM: investment, 2007 initial investment of TVM 2007-01-01
Subitec–SEVERAL: investment, 2007 1st financing round incl investor HTGF 2007-01-01
Thermo Fisher–ETH Zürich: mass spectrometry methods, 2007– collab developm proteomic biomarker approaches incl iSRM technology + Pinpoint s/w B Domon 2007-01-01
Greenovation–SEVERAL: investment, 200611 2nd financing round €5.4m incl new + lead investor Zukunftsfonds Heilbronn with €3.5m 2006-11-25
Greenovation–Zukunftsfonds Heilbronn: investment, 200611 2nd financing round totalling €5.4m incl new + lead investor ZFHN with €3.5m 2006-11-25
UCB–Kinaxo: mass spectrometry services, 200611– supply services using KinaTor technology to support lead optimisation 2006-11-06
LPI Light Power Instruments–JPK Instruments: investment, 200608 acquisition 100% by JPK 2006-08-01
Kinaxo–SEVERAL: investment, 200607 seed financing round €600k High-Tech Gründerfonds + Founders + BioM AG 2006-07-27
CHILL-ON project–Hochschule Bremerhaven: food safety, 200607–201012 FP6 Integrated Project incl partner + project co-ordinator ttz Bremerhaven 2006-07-01
CHILL-ON project–Q-Bioanalytic: food safety, 200607–201012 FP6 Integrated Project incl SME partner Q-Bioanalytic GmbH 2006-07-01
Max Planck–Waters: mass spectrometer, 200606c–200711c supply Synapt HDMS System as one of 1st customers 2006-06-01
4SC–SEVERAL: investment, 200605 capital increase €4,3m placement of 931.3k shares €4.65/share to institutional investors 2006-05-11
Cedi-Diagnostics–Prionics: investment, 200603 acquisition €na 2006-03-14
Boehringer–KMG Chemicals: investment, 200602 acquisition animal insecticide business of Boehringer Ingelheim Vetmedica Inc 2006-02-22
GAT Gamma Analysentechnik–Nordantec: investment, 200602 acquisition of assets of GAT by Nordantec 2006-02-01
Debiopharm–Dr. Reddy’s: drug discovery services, 2006– collab service by Aurigene 2006-01-01
Invitrogen–Biomeva: investment, 2006 management buy-out of BioReliance Manufacturing GmbH from Invitrogen Europe Ltd RENAMED Biomeva GmbH 2006-01-01
Roche–AC Immune: therapeutic antibodies, 2006– license excl for anti-Abeta program to Genentech 2006-01-01
Serono–Newron: safinamide, 2006–201110 collab + excl ww license for developm + manufacturing + commercialisation TERMINATED 10/11 by Merck Serono 2006-01-01
Trimed Biotech–AOP Orphan: investment, 2006 acquisition 2006-01-01
Umetrics–MKS Instruments: investment, 2006 acquisition by MKS Instruments 2006-01-01
Bruker BioSciences–Germany (govt): grant, 200512– BMBF grant for developm mass spec-based RA test by Bruker Daltonik + Panatecs + Univ Göttingen 2005-12-20
Panatecs–Germany (govt): grant, 200512– BMBF grant for developm mass spec-based RA test by Panatecs + Bruker Daltonik + Univ Göttingen 2005-12-20
Univ Alberta–Bruker BioSciences: mass spectrometer, 200512 supply purchase Bruker 9.4T Apex-Qe FTICR by Dept Chemistry MS Facility 2005-12-01
Agennix–SEVERAL: investment, 200503 private placement $22m 2005-03-30
Schott–Adcuram: investment, 200503 acquisition of Duran Group by Adcuram 2005-03-01
Bruker BioSciences–GeneBio: Phenyx MS software, 200502– collab multi-y ww distribution of Phenyx by Bruker Daltonics with own MS s/w + systems 2005-02-03
Actelion–Enamine: chemical compound library, 2005– collab supply of screening compound library to Actelion 2005-01-01
Evotec–TVM: investment, 2005 initial investment of TVM 2005-01-01
GPC–TVM: investment, 2005 initial investment of TVM 2005-01-01
BASF–Jacobs Univ: SeSaM technology, 200409 license existent filed US + EP patents assigned to BASF AG 2004-09-30
KaVo Dental–Danaher: investment, 2004 acquisition €350m by Danaher 2004-01-01
Bioserv AG–NONE: investment, 200304– bankruptcy filed Local Court Rostock 2003-04-11
BMS–Lonza: biologics contract manufacturing, 2003– supply of commercially marketed biological drug by Lonza 2003-01-01
BMS–Lonza: biologics contract manufacturing, 201410– expansion supply €na incl 2nd commercially marketed biological drug by Lonza 2003-01-01
Chandler Instruments–AMETEK: investment, 2003 acquisition of Chandler Instruments by AMETEK 2003-01-01
Inula–Metrohm: investment, 2003 acquisition 2003-01-01
ETG GmbH–Analytik Jena: investment, 2002 acquisition of 20% share by Analytik Jena AG 2002-01-01
Grabner Instruments–Chandler Instruments: investment, 2002 acquisition of Grabner by Chandler 2002-01-01
NatLifE 2020 project–BRAIN: food biotechnology, 2011– partner + coordinator NatLifE 2020 alliance with 22 partners 2001-11-01
Cardion–ROI Verwaltungsgesellschaft: investment, 200107 existent 2001-07-08
Kourion Therapeutics–ROI Verwaltungsgesellschaft: investment, 200107 existent 2001-07-08
Biocentric–Hain Lifescience: molecular diagnostics, 2001– exclusive distributor of Hain products in France 2001-01-01
Glycotope–Eckert Wagniskapital: investment, 2001 founding investor Eckert Wagniskapital und Frühphasenfinanzierung GmbH 2001-01-01
International Univ Bremen–Bremen (govt): credit, 2003 loan guarantee for €50m given by Federal State of Bremen 2001-01-01
International Univ Bremen–Bremen (govt): grant, 2001 start financing support €230m from Federal State of Bremen 2001-01-01
Selexis–SEVERAL: investment, 2001 seed financing CHF100k 2001-01-01
CLIB 2021 Cluster–Protagen: industrial biotechnology, 2010 collab Protagen is project partner of CLIB 2021 2000-01-01
HD Technologies–Thermo Electron: investment, 200001 acquisition of HD Technologies Ltd by Thermo Finnigan (Masslab Ltd) 2000-01-01
OncoTyrol project–Protagen: cancer diagnostics, 2010 collab existent Protagen is project partner of OncoTyrol 2000-01-01
Evolva–SEVERAL: investment, 200910 financing round Series B 1st tranche CHF28m 1999-10-22
Evolva–SEVERAL: investment, 200912 financing round Series B 2nd tranche CHF16m incl new + lead investor Entrepreneurs Fund 1999-10-22
Evolva–Ventureast: investment, 200912– commitment to invest CHF5m in Evolva Biotech Pvt Ltd by Ventureast Trustee Co Pvt Ltd 1999-10-22
Boehringer Mannheim–Roche: investment, 1998 acquisition by Roche 1998-01-01
Dima–Meikang Biotech: rapid diagnostics, 1998– distribution of lateral flow quick tests in Europe by Dima GmbH 1998-01-01
TopLab–Aventis: investment, 1998 Aventis R&D acquires 24.7% in connection with strategic partnership 1998-01-01
Univ Ulm–Bruker Daltonics: mass spectrometer, 1998 supply Bruker Daltonics REFLEX III MALDI-TOF accord to web site of Service Center Mass Spec 1998-01-01
Eurofins–SEVERAL: investment, 199710 IPO 1997-10-24
Novartis–Yoshitomi Pharmaceutical: fingolimod, 199709– license ww for immunosuppressant FTY720 1997-09-24
Hoechst–Clariant: investment, 1997 acquisition of Hoechst Speciality Chemical Business by Clariant 1997-01-01
Techlab–DataApex: chromatography s/w, 1995– distribution of Clarity s/w by Techlab GmbH 1995-01-01
Univ Ulm–Thermo Electron: mass spectrometer, 1994 supply Finnigan MAT SSQ-7000 accord to web site of Service Center Mass Spec 1994-01-01
Univ Ulm–Thermo Electron: mass spectrometer, 1994 supply Finnigan MAT TSQ-700 accord to web site of Service Center Mass Spec 1994-01-01
Univ Ulm–Thermo Electron: mass spectrometer, 1994 supply Finnigan MAT TSQ-7000 accord to web site of Service Center Mass Spec 1994-01-01
Brechbühler–Phenomenex: chromatography consumables, 1991–201708 distribution in Switzerland by Brechbühler TERMINATED 9/17 1991-01-01
Roche–Sigma-Aldrich: investment, 1989 acquisition of Fluka from Roche + Ciba-Geigy by Sigma-Aldrich 1989-01-01
Columbus Pharmaceutical–Boehringer: investment, 1978 acquistion by Boehringer + renamed Roxane Laboratories Inc 1978-01-01
Roche–Hitachi: immunoassay analyser, 1978– collab strategic alliance developm + production of instruments + automated workflows 1978-01-01
Agilent–Univ Duisburg-Essen: analytical technology, 201804– collab with new Agilent sponsored Teaching + Research Center for Separation (TRC) at UDE
AiCuris–SEVERAL: investment, 201004 financing round Series B €55m from existing investors led by Santo Holding
Biotest–Merck (DE): investment, 201103 acquisition of Biotest microbiology business incl heipha Dr Müller GmbH + Hycon by Merck
Cellestia Biotech–SEVERAL: investment, 201701 seed financing round Series C CHF5.2m from Sotio/PPF Group + private investors
Cellestia Biotech–SEVERAL: investment, <2017 seed financing round Series A CHF0.5m
Cellestia Biotech–SEVERAL: investment, <2017 seed financing round Series B CHF2.3m
Eckert & Ziegler–Eckert Wagniskapital: investment, 19?? founding investor Eckert Wagniskapital und Frühphasenfinanzierung GmbH
Greenovation–Zukunftsfonds Heilbronn: investment, 201105 existent Greenovation listed as part of portfolio
OTHER–Novartis: investment, 201401 acquisition of biologics manufacturing faciltiy in Longmont CO by AveXis
R-Biopharm–EuroProxima: research antibodies, 201710 acquisition of research antibody line from EuroProxima BV by Progen Biotechnik GmbH
SimplicityBio–TATAA Biocenter: biomarker services, 201610– collab product integration to offer complete biomarker solutions
Sprout Pharmaceuticals–Boehringer: flibanserin, <201303 acquisition of flibanserin from Boehringer Ingelheim
Vivoryon–Trophic Communications: public relations, 201910 service existent by Trophic
ZIM Plant Technology–Yara: investment, 201311–201401 acquisition by Yara
next pagenext page 1 2 3 ... 53 54 55



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 650x65px

» top